Indication

Non-functioning Entero-pancreatic Endocrine Tumour

1 clinical trial

1 product

Clinical trial

Open Label Extension Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero-pancreatic Endocrine Tumour

Status: Completed, Estimated PCD: 2015-12-01

Product